Article History
Received: 18 August 2020
Revised: 25 August 2020
Accepted: 28 August 2020
First Online: 22 September 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Not applicable.
: R.D.P. has undertaken speaking, consulting and advisory roles for Eli Lilly, BMS, Pfizer, Sanofi, Servier; and received research funding (not related to the work in this manuscript) from Astra Zeneca, Roche, MSD, Merck serrano, Eli Lilly, Five Prime Therapeutics, Clovis, Boston Biomedical and Janssen.
: No specific funding was provided to the authors for this manuscript.